LHCS researchers Golding, Crea, Bacon and Stramek have assembled an international team to examine the genetic changes that occur in response to radiotherapy in the highly aggressive childhood brain cancer, known as DIPG. Radiotherapy is the only approved treatment for DIPG, but patients generally fail to respond after a few months and then the disease continues. Tragically, the average survival time for DIPG is only 6-8 months.